SKQ Project
Science
Overview
History
Molecule
Oxidative stress
Anti-Ageing
Biotechnology
Overview
Mechanism of action
Safety
Ophthalmology
Inflammation
Neurodegeneration
Publications
Theory
Mechanism of Action
Immunology and inflammation
Neurodegeneration
Ophthalmology
Ischemia-related damage
Anti-ageing
Project
Summary
News
Contact Us
Mitotech EU
News
01/10/2016
Results of SkQ1 U.S. Phase 2 Clinical Study in Patients with Dry Eye Syndrome published in Advances in Therapy journal
12/27/2015
Results of Mitotech’s Multicenter Clinical Study in Patients with Dry Eye Syndrome published in Advances in Therapy journal
04/23/2015
Mitotech Announces Phase 2 Data Showing Positive Effect of SkQ1 in Patients with Dry Eye Syndrome
04/21/2014
Mitotech S.A. announces the initiation of Phase II clinical trial in Dry Eye Patients Utilizing the Controlled Adverse Environment
05/16/2012
Mitotech Russia received approval for marketing Visomitin in Russia
01/12/2012
Mitotech Europe initiated pre-clinical program for SkQ1 compound in the U.S.
09/01/2010
Mitotech Russia received approval for marketing Visomitin in Russia